Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine + Bupivacaine for ESP Block in Spine Surgery
NCT05590234Phase 2Completed
- Sponsor
- October 6 University
- Start
- Nov 2022
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dexmedetomidine in postoperative pain (3 arms), sponsored by October 6 University. Primary endpoints: Postoperative visual analogue scale at 24 hours and Amount of post operative opioid consumption at 24 hours. Started Nov 2022; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05590234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05590234.